Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-008357
Filing Date
2020-09-04
Accepted
2020-09-04 11:01:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 34995
2 filename2.txt TEXT-EXTRACT 11317
  Complete submission text file 0000000000-20-008357.txt   60304
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filed for) CIK: 0001805387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations